Clinical and Imaging Data at 5 Days as a Surrogate for 90-Day Outcome in Ischemic Stroke
Clinical and Imaging Data at 5 Days as a Surrogate for 90-Day Outcome in Ischemic Stroke
复制标题
DOI:
10.1161/strokeaha.108.528976
复制
发表时间:
2009-04-01
期刊:
影响因子:
8.3
通讯作者:
Wagner, Douglas P.
中科院分区:
文献类型:
--
作者:
Johnston, Karen C.;Barrett, Kevin M.;Wagner, Douglas P.
Background and Purpose-A simple, easily measured surrogate outcome measure for use in early treatment trials for acute ischemic stroke therapies would be highly valued. We hypothesized that day-5 NIH stroke scale score (NIHSS) and day-5 diffusion weighted imaging (DWI) volume would predict clinical outcome better than either alone and could be considered as a possible surrogate outcome in early phase acute stroke trials.Methods-The prospective Acute Stroke Accurate Prediction (ASAP) trial included a prespecified subgroup evaluated for early outcome. Logistic regression analysis was used to assess the prediction of modified Rankin (mRankin) of 0 or 1.Results-A total of 204 subjects completed the substudy, and 116 (57%) had excellent outcome at 3 months. The area under the ROC curve (AUC) for day-5 NIHSS predicting 3-month excellent outcome was 0.84; for DWI volume predicting outcome was 0.76, and for the multivariable model combining both was 0.84.Conclusions-The results of the early outcome substudy of the ASAP trial suggest that early stroke severity and infarct volume measures are predictive of 3-month excellent outcome. In our data set the DWI volume does not add clinically relevant information in predicting 3-month outcome. Validation of these results is required. (Stroke. 2009;40:1332-1333.)